INS and obesity disorder: Indeed, with the exception of insulin-induced insulin resistance, virtually every molecular mechanism proposed to explain insulin resistance in obesity since the Randle glucose-FFA cycle, indicate elevated circulating FFA levels as a major driver of insulin resistance [2,3,[17], [18], [19], [20], [21], [22], [23], [24], [25]].